aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company (“aVenture”) is an independent research platform providing information and analysis about startups.
Certain metrics provided by aVenture may seek to assess the risks and opportunities associated with a company, fund, or its representatives (collectively “research”). aVenture seeks to provide this information with objectivity and fairness, and with diligence about its accuracy. Nonetheless, aVenture cannot provide assurance as to the accuracy of the information provided by our research. We strongly advise those using the research platform to seek multiple, independent sources for your research when making financial decisions.
Any links provided to other websites are offered as a matter of convenience and are not intended to imply that aVenture or its authors endorse, sponsor, promote, and/or are affiliated with the owners of or participants in those sites.
The aVenture platform also provides investment listings offered by independent investment advisers in the United States. aVenture is neither a registered investment adviser nor an exempt reporting adviser under the Investment Advisers Act of 1940, and no statements made by aVenture are intended to imply any financial instruments are under the counsel or advice of aVenture or its representatives.
Funds offered on the platform are generally managed by a private investment adviser that, unless stated otherwise, claims exemption from SEC or state registration. Investment funds presented on the platform are only available to investors who meet the requirements of the offering, and solicitations are not made outside those listed jurisdictions.
Additionally, each investment offered on the platform has qualifications for eligibility, including some offered only to Qualified Clients and/or Accredited Investors. Certain funds may be available to non-Qualified or Accredited investors, but only those who become personally known and identifiable to aVenture Investment Company staff, who have had an opportunity to assess the financial capacity and suitability for such an investment, and discuss its risks. Funds, when offered, are only offered following a review of a Private Placement Memorandum (PPM), subscription agreement, and other disclosures.
Investments in startups, venture capital, angel investments, private equity, real estate, stocks, and similar asset classes all involve risks, including: the risk of a decline in the value of your investments, including potentially large declines (suddenly and/or for long periods of time), the potential for illiquidity where part or all of a withdrawal request may not be honored on the date requested (even when a feature of the fund). These risks are heightened during periods of market duress.
Diversification has the possibility of reducing the magnitude of declines (either caused by market/economic factors, or by factors related to the individual company), but does not guarantee these risks have been fully or partially alleviated. Most importantly, past results are not an assurance of future outcomes. While most of these risks are shared and similarly held by other investment asset classes, we recommend investors only consider venture capital investments as part of a broader, diversified portfolio of stocks, bonds, and immediately accessible cash reserves.
From Startups | TechCrunch
By Julie Bort
March 21, 2024
Exactly how much Microsoft is paying all the investors of Inflection AI as part its oddly structured deal to abscond with the co-founders, much of the staff and the rights to use the tech hasn’t been publicly revealed. And Microsoft declined comment when asked.
But unnamed sources tell The Information that it’s plunking out approximately $650 million: $620 million for non-exclusive licensing fees for the technology (meaning Inflection is free to license it elsewhere) and $30 million for Inflection to agree not to sue over Microsoft’s poaching, which includes co-founders Mustafa Suleyman and Karén Simonyan.
Microsoft board member Reid Hoffman, also a co-founder of Inflection and an investor in it, along with his VC firm Greylock, did promise “that all of Inflection’s investors will have a good outcome today, and I anticipate good future upside,” in a LinkedIn post earlier this week.
Investors in the early $225 million round will be getting 1.5 times their investment; those in the later $1.3 billion round will get 1.1 times their investment, according to The Information. While that math doesn’t add up to $650 million, these investors will also retain their equity in the skeleton of the startup that remains. The new company, however, will be pivoting away from building a personalized AI chatbot named Pi on a massive computer structure of 22,000 of Nvidia’s expensive, hard-to-find AI chips. It will now become an AI studio helping other companies work with large language model AI.
Inflection did not respond to a request for comment.
In its short life as an aspiring OpenAI competitor — it was founded in 2022 — Inflection raised its more than a billion at a $4 billion valuation — from a who’s who: Microsoft co-founder Bill Gates, Microsoft itself, as well as former Google CEO Eric Schmidt, Dragoneer Investment Group, Nvidia and others.
Just to state the obvious: Microsoft provided a soft landing for Gates (who is technically no longer with the company but still a godlike figure there) and its board member’s VC firm, for their expensive, and possibly fruitless AI venture. The big cloud vendors have all already lined up with other chatbot partners: Microsoft with OpenAI, Google and Amazon with Anthropic, Cohere picking up assorted others like Oracle and Salesforce.
If and when Inflection ever perfected Pi on its enormous AI infrastructure, the race looked to be already lost.
Interestingly, the money Microsoft is spending to gut this startup may be worth it. True, Suleyman has a somewhat cloudy reputation as a boss, according a 2021 investigation by The Wall Street Journal that alleged bullying behavior. But Microsoft itself, while kinder and softer under CEO Satya Nadella, still has a long history as a tough workplace.
And who better to hire than the founder and technical geniuses behind Google DeepMind, now with experience building an LLM? The co-founders are familiar with Google’s secrets well as next-gen AI. Simonyan, for instance, helped spearhead AlphaZero, the AI that mastered the board game Go.
Despite close ties with OpenAI, Microsoft also has many reasons to be needing a backup for its all-important AI gambit. For one, the FTC said it’s looking into its deal with OpenAI, as well as Anthropic’s deals with Amazon and Google. Should some sort of FTC mandates be issued, Microsoft would be wise to have options.
Plus, word is that some of Microsoft’s engineers and OpenAI’s engineers don’t have the most loving relationship, Business Insider has reported. Then there was the Sam Altman firing saga that had Nadella telling the world he was absorbing Altman and much of OpenAI, only to walk it back.
There are so many red flags with OpenAI that Microsoft is wise to wean its dependence.
Then again, just like Microsoft’s investment in OpenAI, we wonder if regulators will also have something to say about this deal.
View original article on techcrunch.com
Share:
Xaira, an AI drug discovery startup, launches with a massive $1B, says it’s ‘ready’ to start developing drugs
Advances in generative AI have taken the tech world by storm. Biotech investors are making a big bet that similar computational methods could revolutionize drug discovery. On Tuesday, ARCH Venture Partners and Foresite Labs, an affiliate of Foresite Capital, announced that they incubated Xaira Therapeutics and funded the AI biotech with $1 billion. Other investors […] © 2024 TechCrunch. All rights reserved. For personal use only.
Apr 25, 2024
Eric Schmidt-backed Augment, a GitHub Copilot rival, launches out of stealth with $252M
AI is supercharging coding — and developers are embracing it. In a recent StackOverflow poll, 44% of software engineers said that they use AI tools as part of their development processes now and 26% plan to soon. Gartner estimates that over half of organizations are currently piloting or have already deployed AI-driven coding assistants, and […] © 2024 TechCrunch. All rights reserved. For personal use only.
Apr 24, 2024
Radical thinks the time has come for solar-powered, high-altitude autonomous aircraft
Though many eyes are on space as orbit develops into a thriving business ecosystem, Radical is keeping things a little closer to the ground — but not too close. Its high-altitude, solar-powered aircraft aim to succeed where Facebook’s infamous Aquila failed by refining the tech and embracing more markets. It’s hard to believe that Facebook’s […] © 2024 TechCrunch. All rights reserved. For personal use only.
Apr 24, 2024
Don't miss our latest news and updates. Subscribe to the newsletter
More from Tech Crunch: